Skip to main content
. 2024 May 24;103(21):e37972. doi: 10.1097/MD.0000000000037972

Figure 2.

Figure 2.

Progression of metastatic disease during crizotinib treatment (A) in all patients, (B) according to gender, and (C) according to smoking status.